Cite
Neuber B, Dai J, Waraich WA, et al. Lenalidomide overcomes the immunosuppression of regulatory CD8. Oncotarget. 2017;8(58):98200-98214doi: 10.18632/oncotarget.21516.
Neuber, B., Dai, J., Waraich, W. A., Awwad, M. H. S., Engelhardt, M., Schmitt, M., Medenhoff, S., Witzens-Harig, M., Ho, A. D., Goldschmidt, H., & Hundemer, M. (2017). Lenalidomide overcomes the immunosuppression of regulatory CD8. Oncotarget, 8(58), 98200-98214. https://doi.org/10.18632/oncotarget.21516
Neuber, Brigitte, et al. "Lenalidomide overcomes the immunosuppression of regulatory CD8." Oncotarget vol. 8,58 (2017): 98200-98214. doi: https://doi.org/10.18632/oncotarget.21516
Neuber B, Dai J, Waraich WA, Awwad MHS, Engelhardt M, Schmitt M, Medenhoff S, Witzens-Harig M, Ho AD, Goldschmidt H, Hundemer M. Lenalidomide overcomes the immunosuppression of regulatory CD8. Oncotarget. 2017 Oct 05;8(58):98200-98214. doi: 10.18632/oncotarget.21516. eCollection 2017 Nov 17. PMID: 29228683; PMCID: PMC5716723.
Copy
Download .nbib